Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response

After neoadjuvant chemoradiotherapy for esophageal adenocarcinoma, up to 29% of patients have a pathological complete response (pCR). What to do afterward is still under debate. The aim of this prospective study was to define which local markers of immune response might act as predictors of pCR and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncoimmunology
Hoofdauteurs: Kotsafti, Andromachi, Scarpa, Melania, Cavallin, Francesco, Fassan, Matteo, Salmaso, Roberta, Porzionato, Andrea, Saadeh, Luca, Cagol, Matteo, Alfieri, Rita, Castoro, Carlo, Rugge, Massimo, Castagliuolo, Ignazio, Scarpa, Marco
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458640/
https://ncbi.nlm.nih.gov/pubmed/32923165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1804169
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items